cid-103
Generic: Anti-CD38 Monoclonal Antibody CID-103
cid-103: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| CASI Pharmaceuticals, Inc (DE) (CASI) | Phase 1 |
Get deeper analysis on cid-103
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis